ADAMAS Consulting’s webinar, “GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs,” provides invaluable insights into the evolving landscape of Good Clinical Practice (GCP) guidelines. Experts discuss key updates to ICH E6 R3 and how Sponsors and CROs can navigate these changes in clinical trials.
On January 6, 2025, a major revision to the ICH E6 guidelines was finalized, marking the beginning of a significant shift in the regulatory landscape. During the implementation phase, regulators will define the mandatory adoption timeline for these changes, making it imperative for industry professionals to understand and adapt to the evolving requirements.
Key Insights:
- In-depth Analysis: Learn about the key structural and content changes introduced in ICH E6 R3 and their impact on clinical trial oversight.
- Evolving Roles: Understand the revised responsibilities of sponsors and Contract Research Organizations (CROs), including shifts in study oversight, risk-based quality management, and overall accountability.
- Strategic Insights: Gain expert perspectives on how to effectively implement updated Good Clinical Practice (GCP) requirements to ensure continuous regulatory compliance and optimize trial efficiency.
Missed the webinar? You can watch the full recording here or check out our summary guide for the key takeaways.
Expert Speakers:
With decades of combined regulatory and industry expertise, Dr. Ferrão and Ms. Hutton share practical strategies and actionable insights tailored for professionals at all levels.
Dr. Elsa Ferrão – GCP Principal Consultant at ADAMAS Consulting
Penelope Hutton – GCP Senior Consultant at ADAMAS Consulting
